Proficio Capital Partners LLC Insmed Inc Transaction History

Proficio Capital Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	BUY	$66.29 - $76.63 $1.79 Million - $2.07 Million	26,995 New	26,995 $1.86 Million
Q1 2021 May 14, 2021	SELL	$32.28 - $44.3 $399,723 - $548,566	-12,383 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$31.45 - $40.54 $377 - $486	-12 Reduced 0.1%	12,383 $412,000
Q2 2020 Aug 14, 2020	SELL	$14.11 - $29.42 $945 - $1,971	-67 Reduced 0.54%	12,395 $341,000
Q1 2020 May 06, 2020	BUY	$13.63 - $33.98 $169,857 - $423,458	12,462 New	12,462 $200,000
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $2,137 - $3,557	-138 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$23.0 - $32.19 $897 - $1,255	-39 Reduced 22.03%	138 $4,000
Q1 2019 May 13, 2019	BUY	$13.91 - $31.15 $2,462 - $5,513	177 New	177 $5,000

484

187M

2.15M

3.22M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.7B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.